NCT04111354

Brief Summary

Permanent pacemaker implantation is one of the most common arrhythmological procedure. This procedure is usually accompanied by a minimum of 2-3 days hospitalization, with immobilization of patients (supine) for 16-24 hours. The optimal duration of patient´s immobilization is not determined. There is also no recommendation from individual manufacturers of pacemakers for the duration of immobilization after pacemaker implantation. The length of immobilization is based rather on the tradition established at the time of using electrodes with passive fixation. The aim of our prospective, randomized study (EMAPI) is to compare the safety of short-term (4-hours) immobilization with long-term (16-24 hours) immobilization after primary pacemaker implantation. Septal position will be used for right ventricular electrode.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 28, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 6, 2019

Completed
25 days until next milestone

First Posted

Study publicly available on registry

October 1, 2019

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

5.4 years

First QC Date

September 6, 2019

Last Update Submit

October 9, 2024

Conditions

Keywords

pacemakerimplantationmobilizationcomplication

Outcome Measures

Primary Outcomes (1)

  • Composite endpoint of incidence of adverse events from secondary outcomes depending on the length of immobilization (early vs. late).

    Comparsion of incidence of dislodgement of atrial electrode, dislodgement of ventricular electrode in septal position, hematoma surgically treated or requiring blood transfusions, pneumothorax, pocket infection, others complications

    6 months

Secondary Outcomes (6)

  • Incidence of atrial lead dislodgement.

    6 months

  • Incidence of ventricular lead dislodgement.

    6 months

  • Incidence of hematoma (surgically treated or requiring blood transfusions.)

    6 months

  • Incidence of pneumothorax.

    24 hours

  • Incidence of pocket infection.

    6 months

  • +1 more secondary outcomes

Study Arms (2)

Short-term (4-hours) immobilization.

ACTIVE COMPARATOR

Short-term (4-hours) immobilization after primary pacemaker implantation.

Device: Pacemaker implantation

Long-term (16-24 hours) immobilization.

ACTIVE COMPARATOR

Long-term (16-24 hours) immobilization after primary pacemaker implantation.

Device: Pacemaker implantation

Interventions

Pacemaker implantation

Long-term (16-24 hours) immobilization.Short-term (4-hours) immobilization.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years and older.
  • Indication for permanent pacemaker implantation.
  • Mobile and compliant patient.
  • Willing and able to give written informed consent.

You may not qualify if:

  • Imobile and noncompliant patient.
  • Indication of CRT implantation.
  • Upgrade or revision of implanted devise.
  • Contraindications to pacemaker implantation.
  • Gravidity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jiri Smid, Cardiology department, University Hospital and Faculty of Medicine in Pilsen, Charles University, Czech Republic

Pilsen, 32300, Czechia

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

September 6, 2019

First Posted

October 1, 2019

Study Start

March 28, 2019

Primary Completion

August 31, 2024

Study Completion

August 31, 2024

Last Updated

October 15, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations